The FDA has approved Vykat XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years ...

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

Daily cocoa extract and multivitamin/multimineral supplementation are not associated with a reduced risk for fracture among older adults.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

Up to 30% of acute kidney injury (AKI) survivors require dialysis and personalized care after discharge from the hospital.

The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.

Postmenopausal women with CSA were associated with an increased risk of developing ACPA-negative IA and progressing to RA.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains questionable.

The Trump administration will lay off 10,000 workers at the US Department of Health and Human Services as part of a major reorganization.

Lonapegsomatropin demonstrated efficacy outcomes superior to daily somatropin in treatment of pediatric growth hormone deficiency.